Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy

Introduction: Chimeric antigen receptor T-cell (CAR-T) therapy is an innovative therapeutic option for addressing certain recurrent or refractory hematological malignancies. However, CAR-T cells also cause the release of pro-inflammatory cytokines that lead to life-threatening cytokine release syndr...

Full description

Bibliographic Details
Main Authors: Puri Ferreros, Isabel Trapero
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Diseases
Subjects:
CAR-T cells
cytokine release syndrome
neurotoxicity
interleukin inhibitors
Online Access:https://www.mdpi.com/2079-9721/10/3/41

Internet

https://www.mdpi.com/2079-9721/10/3/41

Similar Items